COPD, die Systemerkrankung: Ernährung: zu wenig beachtet und noch ungelöst

Gratiana Steinkamp

doi:10.1055/s-2003-44265

Pneumologie, Table of Contents

Pneumologie 2003; 57(11): 681-689
DOI: 10.1055/s-2003-44265

Workshop

COPD, die Systemerkrankung: Ernährung: zu wenig beachtet und noch ungelöst

COPD, the Systemic Disease: Nutrition - an Underestimated and Unresolved ProblemGratiana Steinkamp¹

¹Klinische Forschung, Medizinisch-wissenschaftliches Publizieren

Experten-Workshop am 11. und 12. Juli 2003 in Fleesensee. Leitung: Prof. Dr. Harald Morr. GreifensteinUnterstützungBoehringer Ingelheim Pharma GmbH & Co KG, Ingelheim

Abstract

Full Text

References

Literatur

1 Landbo C, Prescott E, Lange P. et al . Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 160 1856-1861
2 Pouw E M, Ten Velde G P, Croonen B H. et al . Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr. 2000; 19 95-99
3 Bernard S, LeBlanc P, Whittom F. et al . Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 158 629-634
4 Schols A M, Soeters P B, Dingemans A M. et al . Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993; 147 1151-1156
5 Gosker H R, Mameren H van, Dijk P J van. et al . Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002; 19 617-625
6 Maltais F, LeBlanc P, Whittom F. et al . Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax. 2000; 55 848-853
7 Franssen F M, Wouters E F, Baarends E M. et al . Arm mechanical efficiency and arm exercise capacity are relatively preserved in chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2002; 34 1570-1576
8 Gosker H R, Schrauwen P, Hesselink M K. et al . Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD. Eur Respir J. 2003; 22 88-93
9 Creutzberg E C, Wouters E F, Mostert R. et al . Efficacy of nutritional aupplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition. 2003; 19 120-127
10 Nguyen L T, Bedu M, Caillaud D. et al . Increased resting energy expenditure is related to plasma TNF-alpha concentration in stable COPD patients. Clin Nutr. 1999; 18 269-274
11 Morrison W L, Gibson J N, Scrimgeour C. et al . Muscle wasting in emphysema. Clin Sci (Lond). 1988; 75 415-420
12 Schols A M, Slangen J, Volovics L. et al . Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157 1791-1797
13 Schols A M, Wesseling G, Kester A D. et al . Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J. 2001; 17 337-342
14 The COPD Guidelines Group of the Standards of Care Committee of the BTS . BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax. 1997; 52 Suppl 5 1-28
15 Global Initiative for Chronic Obstructive Lung Disease .Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report, Executive Summary. 2701A. 2001 National Institutes of Health. National Heart, Lung, and Blood Institute. World Health Organisation
16 Worth H, Buhl R, Cegla U. et al . Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft fur Pneumologie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie. 2002; 56 704-738
17 Harik-Khan R I, Fleg J L, Wise R A. Body mass index and the risk of COPD. Chest. 2002; 121 370-376
18 Mannino D M, Buist A S, Petty T L. et al . Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003; 58 388-393
19 Arif A A, Delclos G L, Lee E S. et al . Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data. Eur Respir J. 2003; 21 827-833
20 Guerra S, Sherrill D L, Bobadilla A. et al . The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest. 2002; 122 1256-1263
21 Chailleux E, Laaban J P, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest. 2003; 123 1460-1466
22 Marquis K, Debigare R, Lacasse Y. et al . Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002; 166 809-813
23 Gesundheitsberichterstattung des Bundes - Robert Koch Institut .Gesundheitsbericht für Deutschland 1998. 1998: 1-11
24 Bang K M, Gergen P J, Kramer R. et al . The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest. 1993; 103 536-540
25 Hole D J, Watt G C, Davey-Smith G. et al . Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996; 313 711-715
26 Schunemann H J, Dorn J, Grant B J. et al . Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000; 118 656-664
27 Engstrom G, Lind P, Hedblad B. et al . Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation. 2002; 106 2555-2560
28 Behar S, Panosh A, Reicher-Reiss H. et al . Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med. 1992; 93 637-641
29 Sin D D, Man S F. Why are patients with chronic obstructive pulmonary disease an increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003; 107 1514-1519
30 Anker S D, Ponikowski P, Varney S. et al . Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997; 349 1050-1053
31 Anker S D, Negassa A, Coats A J. et al . Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003; 361 1077-1083
32 Anker S D, Coats A J. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation. 1997; 95 538-539
33 Meyer P A, Mannino D M, Redd S C. et al . Characteristics of adults dying with COPD. Chest. 2002; 122 2003-2008
34 Vermeeren M A, Wouters E F, Nelissen L H. et al . Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2001; 73 295-301
35 McKeever T M, Scrivener S, Broadfield E. et al . Prospective study of diet and decline in lung function in a general population. Am J Respir Crit Care Med. 2002; 165 1299-1303
36 Habib M P, Tank L J, Lane L C. et al . Effect of vitamin E on exhaled ethane in cigarette smokers. Chest. 1999; 115 684-690
37 Weisberg J, Wanger J, Olson J. et al . Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest. 2002; 121 1070-1078
38 Burdet L, Muralt B de, Schutz Y. et al . Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med. 1997; 156 1800-1806
39 Schols A M, Soeters P B, Mostert R. et al . Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995; 152 1268-1274
40 Ferreira I M, Verreschi I T, Nery L E. et al . The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest. 1998; 114 19-28
41 Yeh S S, DeGuzman B, Kramer T. Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. Chest. 2002; 122 421-428

Priv.-Doz. Dr. med. Gratiana Steinkamp

Klinische Forschung · Medizinisch-wissenschaftliches Publizieren

Schellingstr. 5a

30625 Hannover

Email: steinkamp@med-wiss.com

URL: http://www.med-wiss.com